Impaired dopamine release and uptake in R6/1 Huntington's disease model mice

被引:27
|
作者
Ortiz, Andrea N. [1 ,2 ]
Kurth, Benjamin J. [1 ,2 ]
Osterhaus, Gregory L. [1 ,2 ]
Johnson, Michael A. [1 ,2 ,3 ]
机构
[1] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA
[2] RN Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA
[3] Neurosci Program, Lawrence, KS 66045 USA
关键词
Dopamine; Voltammetry; Huntington's disease; R6/1; mice; Release; Uptake; MOUSE MODEL; GENE; DYSFUNCTION; REPEAT; EXON-1;
D O I
10.1016/j.neulet.2011.01.036
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a progressive, neurodegenerative movement disorder. Here, we used fast-scan cyclic voltammetry to measure dopamine release and uptake in striatal brain slices from R6/1 HD model mice. Peak dopamine release ([DA](max)) was significantly diminished in R6/1 mice (52% of wild-type at 24 weeks of age). Similarly, dopamine released per locally applied electrical stimulus pulse ([DA](p)), which is [DA](max) corrected for uptake and electrode performance, was also diminished in R6/1 mice (43% of wild-type by 24 weeks of age). Moreover, V-max, the maximum rate of dopamine uptake, obtained by modeling the stimulated release plots, was decreased at 16 and 24 weeks of age in R6/1 mice (51 and 48% of wild-type, respectively). Thus, impairments in both dopamine release and uptake appear to progress in an age-dependent manner in R6/1 mice. (C) 2011 Published by Elsevier Ireland Ltd.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 50 条
  • [1] Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease
    Johnson, MA
    Rajan, V
    Miller, CE
    Wightman, RM
    JOURNAL OF NEUROCHEMISTRY, 2006, 97 (03) : 737 - 746
  • [2] IKKβ slows Huntington's disease progression in R6/1 mice
    Ochaba, Joseph
    Fote, Gianna
    Kachemov, Marketta
    Thein, Soe
    Yeung, Sylvia Y.
    Lau, Alice L.
    Hernandez, Sarah
    Lim, Ryan G.
    Casale, Malcolm
    Neel, Michael J.
    Monuki, Edwin S.
    Reidling, Jack
    Housman, David E.
    Thompson, Leslie M.
    Steffan, Joan S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (22) : 10952 - 10961
  • [3] Late onset vascular dysfunction in the R6/1 model of Huntington's disease
    Rahman, Awahan
    Ekman, Mari
    Shakirova, Yulia
    Andersson, Kristina E.
    Morgelin, Matthias
    Erjefalt, Jonas S.
    Brundin, Patrik
    Li, Jia-Yi
    Sward, Karl
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) : 345 - 353
  • [4] Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington's disease
    Hashimoto, Masayo
    Watanabe, Kenichi
    Miyoshi, Kan
    Koyanagi, Yukako
    Tadano, Jun
    Miyawaki, Izuru
    FEBS OPEN BIO, 2021, 11 (10): : 2807 - 2818
  • [5] Deficits in Spermatogenesis but not Neurogenesis are Alleviated by Chronic Testosterone Therapy in R6/1 Huntington's Disease Mice
    Hannan, A. J.
    Ransome, M. I.
    JOURNAL OF NEUROENDOCRINOLOGY, 2012, 24 (02) : 341 - 356
  • [6] Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease
    Josefsen, K.
    Nielsen, M. D.
    Jorgensen, K. H.
    Bock, T.
    Norremolle, A.
    Sorensen, S. A.
    Naver, B.
    Hasholt, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 (02) : 165 - 172
  • [7] Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice
    Johnson, Michael A.
    Villanueva, Melissa
    Haynes, Christy L.
    Seipel, Andrew T.
    Buhler, Leah A.
    Wightman, R. Mark
    JOURNAL OF NEUROCHEMISTRY, 2007, 103 (05) : 2102 - 2110
  • [8] A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice
    Heath, Christopher J.
    O'Callaghan, Claire
    Mason, Sarah L.
    Phillips, Benjamin U.
    Saksida, Lisa M.
    Robbins, Trevor W.
    Barker, Roger A.
    Bussey, Timothy J.
    Sahakian, Barbara J.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [9] Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington's Disease
    Holley, S. M.
    Oikonomou, K. D.
    Swift, C. M.
    Mohan, L.
    Matthews, B.
    Vega, O.
    Mkrtchyan, G.
    Cepeda, C.
    Levine, M. S.
    ENEURO, 2022, 9 (03)
  • [10] NEUROGENESIS IN THE R6/2 MOUSE MODEL OF HUNTINGTON'S DISEASE IS IMPAIRED AT THE LEVEL OF NEUROD1
    Fedele, V.
    Roybon, L.
    Nordstrom, U.
    Li, J. Y.
    Brundin, P.
    NEUROSCIENCE, 2011, 173 : 76 - 81